Actively Recruiting

Phase 3
All Genders
NCT06530732

Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)

Led by Zhejiang Provincial People's Hospital · Updated on 2025-01-16

60

Participants Needed

1

Research Sites

117 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to To demonstrate the Safety and Efficacy of dcLVA Surgery for the Treatment of Alzheimer's Disease. Patients who meet the inclusion and exclusion criteria and consent to participate will be randomly assigned to either the experimental group (receiving dcLVA surgery plus standard medication) or the control group (receiving standard medication alone) Participants will: Undergo cognitive assessment and brain MRI assessment; Undergo a lumbar puncture; Undergo an injection of 20ml of gadodiamide contrast agent at a concentration of 0.5 mmol/L (1ml gadodiamide: 20ml 0.9% saline). Primary Outcome Measures: The change in the sum of Clinical Dementia Rating Scale (CDR) scores at 12-month in relative to baseline

CONDITIONS

Official Title

Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed as an Alzheimer's Disease patient based on biological markers and clinical symptoms
  • Age over 35 years
  • Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MOCA) score of 26 or less
  • Patient or family member has signed an informed consent form
Not Eligible

You will not qualify if you...

  • Unable to cooperate with lumbar puncture
  • Cognitive impairment caused by neurological infections such as HIV, neurosyphilis, or autoimmune encephalitis, or by systemic diseases like diabetes or thyroid dysfunction
  • Significant dysfunction of heart, lung, liver, or kidney
  • Coagulation disorders or any contraindications to surgery
  • Unable to fully cooperate with follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China, 310014

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here